Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Kronos Bio, Inc. (KRON) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Abstract titled “A First-In-Human Study of CDK9 Inhibitor KB-0742 Demonstrates Evidence of Tolerability and Clinical Activity.”"
08/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial Results Data from the Phase 1 dose escalation portion of the Phase 1/2 KB-0742 study will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in October 2023"
05/30/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/30/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/10/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results Enrollment ongoing in expansion portion of Phase 1/2 KB-0742 study, with initial efficacy data expected in 2H 2023"
04/24/2023 8-K Quarterly results
03/27/2023 8-K Quarterly results
03/27/2023 8-K/A Quarterly results
03/15/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results First patient dosed in expansion portion of KB-0742 Phase 1/2 study, with initial efficacy results expected in 2H 2023"
01/26/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/09/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure  Interactive Data
11/08/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
04/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Kronos Bio, Inc. Compensation Committee of the Board of Directors or Representative"
02/24/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2021 Financial Results Phase 1/2 trial of CDK9 inhibitor KB-0742 continues to enroll patients in the dose escalation stage, with announcement of recommended Phase 2 dose and Phase 1 data expected in Q4 2022"
12/06/2021 8-K Quarterly results
11/29/2021 8-K Other Events  Interactive Data
11/12/2021 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/12/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/09/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Kronos Bio Reports Recent Business Progress and Third-Quarter Financial Results Company today announces progression of two discovery programs within its pipeline"
08/12/2021 8-K Quarterly results
06/24/2021 8-K/A Quarterly results
06/23/2021 8-K Quarterly results
05/25/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
03/26/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
03/04/2021 8-K Quarterly results
02/10/2021 8-K Quarterly results
01/26/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/07/2020 8-K Other Events
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy